about
Congenital thrombocytopenia: clinical manifestations, laboratory abnormalities, and molecular defects of a heterogeneous group of conditions.Thrombocytopenia Pitfalls: Misdiagnosing Type 2B von Willebrand Disease as Ethylenediaminetetraacetic Acid-Dependent Pseudothrombocytopenia.Rare presentations of primary melanoma and special populations: a systematic review.A short course of prednisone in the management of acute chest syndrome of sickle cell disease.Inherited abnormalities of coagulation: hemophilia, von Willebrand disease, and beyond.Inferior vena cava atresia predisposing to acute lower extremity deep vein thrombosis in children: A descriptive dual-center study.Changing Paradigm of Hemophilia Management: Extended Half-Life Factor Concentrates and Gene Therapy.Arterial Ischemic Stroke in Children and Young Adults.Thrombosis of the Abdominal Veins in Childhood.Consequences of delayed therapy for sports-related bleeds in patients with mild-to-moderate haemophilia and type 3 von Willebrand's disease not on prophylaxis.Non-catheter related internal jugular vein thrombosis in a patient with severe haemophilia A.Venous Thromboembolism in Pediatric Hematopoietic Cell Transplant: A Multicenter Cohort Study.aPTT in children receiving UFH: time for a change?Health-related quality of life in children and young adults with post-thrombotic syndrome: results from a cross-sectional study.Mesoaortic compression of a left-sided inferior vena-cava presenting as recurrent pulmonary embolism in a child-a novel anatomic thrombophilia?Venous Thromboembolism in Children with Sickle Cell Disease: A Retrospective Cohort Study.Molecular structural analysis of a novel and de-novo mutation in the SERPINC1 gene associated with type 1 antithrombin deficiency.Pretransplant conditioning with Campath-1H (alemtuzumab) in pediatric matched unrelated hematopoietic stem cell transplants: an institutional experience.Successful treatment of a child with T/myeloid acute bilineal leukemia associated with TLX3/BCL11B fusion and 9q deletion.c.1058C>T variant in theSERPINC1gene is pathogenic for antithrombin deficiencyClinical presentation and molecular basis of congenital antithrombin deficiency in children: a cohort studyPrevalence and risk factors for post thrombotic syndrome after deep vein thrombosis in children: A cohort studyDevelopment and initial validation of a questionnaire to diagnose the presence and severity of post-thrombotic syndrome in childreImpact of aerobic exercise on haemostatic indices in paediatric patients with haemophiliaPostradiation dermatofibrosarcoma protuberans in a patient with Wilms tumorA novel mutation in the SerpinC1 gene presenting as unprovoked neonatal cerebral sinus venous thrombosis in a kindredPrevalence and risk factors for venous thromboembolism in children with sickle cell disease: an administrative database studyTreatment-Related Outcomes in Paget-Schroetter Syndrome-A Cross-Sectional InvestigationPopliteal Artery Entrapment Syndrome Presenting with Critical Limb Ischemia in an AdolescentCatheter-directed thrombolysis for submassive pulmonary embolism in children: A case seriesFibrinogen Columbus II: A novel c.1075G>T mutation in the FGG gene causing hypodysfibrinogenemia and thrombosis in an adolescent maleAnti-Factor Xa-Based Monitoring of Unfractionated Heparin: Clinical Outcomes in a Pediatric Cohort
P50
Q33408009-4598427C-953E-4AFD-AE56-B90038A633C2Q33432456-539D563F-CEC1-4A6C-AD4B-4F259AEDA9ECQ35147046-7B53E5B4-4ABD-4325-8457-5C3B18E33F65Q37705938-05792594-69E0-4712-8DC3-BFCA16B274F4Q38163079-6E3D5DB6-B871-4176-B161-BCA6EE6C124AQ38602518-30E6B664-2EE4-41E1-8A8F-1D9D50E53F27Q38697835-0DC3BD51-08FC-4C8D-B795-96212BC2EA60Q39117929-D023F093-2BA4-418E-82B1-9A19905CCE73Q41457449-6953805F-AC99-43BE-BECF-436AA26E89B7Q43949815-7CC27AF5-9883-467D-90D4-E3428DD3DD1DQ45887899-5A0CB5EA-AC69-4EF1-9F91-ECBE5BAD81DCQ47612935-7467C387-8D24-4EF3-A2D0-7124CDBF99A1Q48111777-DAB21812-C05E-4DBD-9468-87A28632AE3FQ48113752-A16C9092-6B78-4AE1-9D93-DABB559756D7Q48208857-E804637A-15E3-469E-A3D3-A106813D2B55Q52722573-C51037DE-B6E9-4612-BB12-ED48BB01A8A4Q52873934-D10D0183-9EBF-43C0-8A80-6FF1C1F511C0Q53200679-55C2B8B8-59E2-4B8C-9056-D80A9E122CA9Q54393096-A342E8D7-4A48-4CDC-B3AB-79A62A32ED2FQ57202325-C639581E-F3DD-4AE3-92C3-B27193197257Q57202331-66886B0D-BD72-4957-A057-C470BDA5CB17Q57907751-A6FEF4AA-34CF-4818-92C9-18EC5DD46062Q57907831-C594E163-F402-48B5-940F-4AEE2F23BF53Q61872159-545AE082-C2E8-4DB4-A8DC-584BAE6695A8Q83666474-DD4DBFE7-3A31-4815-8FD9-57133F98FCF2Q85009340-9CC6C0E7-CFD2-4B61-B878-F4488AE760E0Q87757679-ECD59B95-8700-4507-9764-E0609D073ABCQ90353280-5C672678-568D-468B-B521-194BB4ECB867Q90670082-2285AB30-FEB3-45C8-828F-CC2697609408Q92245977-BE3DCA48-15E0-4544-9FB2-738DF0BBF481Q92313603-B6130C67-0E46-49E4-8691-21759D4390D6Q92951287-710DFF78-FF52-4291-81FF-CFA46196EDDC
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Riten Kumar
@ast
Riten Kumar
@en
Riten Kumar
@es
Riten Kumar
@nl
Riten Kumar
@sl
type
label
Riten Kumar
@ast
Riten Kumar
@en
Riten Kumar
@es
Riten Kumar
@nl
Riten Kumar
@sl
prefLabel
Riten Kumar
@ast
Riten Kumar
@en
Riten Kumar
@es
Riten Kumar
@nl
Riten Kumar
@sl
P106
P31
P496
0000-0001-8004-4190